What is the official website of Jubilant Pharmova Limited ?

The official website of Jubilant Pharmova Limited is http://www.jubilantpharmova.com.

What is Jubilant Pharmova Limited's cybersecurity risk score?

Jubilant Pharmova Limited has an AI-generated cybersecurity risk score of 758 out of 1000, indicating a Fair security posture according to Rankiteo's assessment.

How many security incidents has Jubilant Pharmova Limited experienced?

According to Rankiteo, Jubilant Pharmova Limited currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has Jubilant Pharmova Limited been affected by any supply chain cyber incidents ?

According to Rankiteo, Jubilant Pharmova Limited has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does Jubilant Pharmova Limited have SOC 2 Type 1 certification ?

According to Rankiteo, Jubilant Pharmova Limited is not certified under SOC 2 Type 1.

Does Jubilant Pharmova Limited have SOC 2 Type 2 certification ?

According to Rankiteo, Jubilant Pharmova Limited does not hold a SOC 2 Type 2 certification.

Does Jubilant Pharmova Limited comply with GDPR ?

According to Rankiteo, Jubilant Pharmova Limited is not listed as GDPR compliant.

Does Jubilant Pharmova Limited have PCI DSS certification ?

According to Rankiteo, Jubilant Pharmova Limited does not currently maintain PCI DSS compliance.

Does Jubilant Pharmova Limited comply with HIPAA ?

According to Rankiteo, Jubilant Pharmova Limited is not compliant with HIPAA regulations.

Does Jubilant Pharmova Limited have ISO 27001 certification ?

According to Rankiteo,Jubilant Pharmova Limited is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does Jubilant Pharmova Limited operate in ?

Jubilant Pharmova Limited operates primarily in the Pharmaceutical Manufacturing industry.

How many employees does Jubilant Pharmova Limited have ?

Jubilant Pharmova Limited employs approximately 8,027 people worldwide.

Does Jubilant Pharmova Limited own any subsidiaries ?

Jubilant Pharmova Limited presently has no subsidiaries across any sectors.

How many LinkedIn followers does Jubilant Pharmova Limited have ?

Jubilant Pharmova Limited's official LinkedIn profile has approximately 212,261 followers.

What is the NAICS classification code for Jubilant Pharmova Limited ?

Jubilant Pharmova Limited is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.

Does Jubilant Pharmova Limited have a Crunchbase profile ?

No, Jubilant Pharmova Limited does not have a profile on Crunchbase.

Does Jubilant Pharmova Limited have a LinkedIn profile ?

Yes, Jubilant Pharmova Limited maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/jubilantpharmova.

How many cybersecurity incidents has Jubilant Pharmova Limited experienced ?

As of August 29, 2026, Rankiteo reports that Jubilant Pharmova Limited has not experienced any cybersecurity incidents.

How many peer or competitor companies does Jubilant Pharmova Limited have ?

Jubilant Pharmova Limited has an estimated 5,746 peer or competitor companies worldwide.

NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop

WindowsmacOSLinux

Download

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

JPL

Boost Score +25 with badge (5 left)

758

/1000

Fair

783

/1000

Fair

Jubilant Pharmova Limited Vendor Cyber Rating & Cyber Score

jubilantpharmova.com

Add Your Compliance Badge

Jubilant Pharmova Limited (formerly Jubilant Life Sciences Limited) is a global integrated pharmaceutical company, advancing healthcare through science, technology and precision execution. It is involved in the businesses of Radiopharma, Allergy Immunotherapy, CDMO Sterile Injectables, Contract Research Development and Manufacturing Organisation (CRDMO), Generics and Proprietary Novel Drugs. In the Radiopharma business, the Company is involved in the manufacturing and supply of Radiopharmaceuticals with a network of 45 radiopharmacies in the US. The Company’s Allergy Immunotherapy business is involved in the manufacturing and supply of allergic extracts and venom products in the US and in some other markets such as Canada, Europe and

JPL A.I CyberSecurity Scoring

Scoring History

JPL

Jubilant Pharmova Limited CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

No data available

Loading…

A.I.

JPL Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for JPL

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Jubilant Pharmova Limited in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for Jubilant Pharmova Limited in 2026.

Incident Types JPL vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Jubilant Pharmova Limited in 2026.

Incident History - JPL (X = Date, Y = Severity)

Loading…

SUBSIDIARY

Jubilant Pharmova Limited Subsidiaries

JPL

Pharmaceutical Manufacturing

Website: http://www.jubilantpharmova.com

Company Size: 5,001-10,000 employees

Jubilant Life Sciences Alumni NetworkPharmaceutical Manufacturing

Jubilant Biosys LimitedResearch

Jubilant Chemsys -> Jubilant Biosys LimitedPharmaceutical Manufacturing

Jubilant Generics LimitedPharmaceutical Manufacturing

Jubilant RadiopharmaPharmaceutical Manufacturing

Jubilant Pharma LimitedPharmaceutical Manufacturing

Jubilant HollisterStier CMOPharmaceutical Manufacturing

Sterile Ophthalmics & OticsPackaging & Containers

Non-Sterile Topicals and LiquidsPharmaceutical Manufacturing

High Speed Ampoule FillingPharmaceutical Manufacturing

Jubilant Therapeutics IncBiotechnology

Jubilant Cadista PharmaceuticalsPharmaceutical Manufacturing

HollisterStier AllergyPharmaceutical Manufacturing

Loading…

Jubilant Pharmova Limited Similar Companies

Torrent Pharmaceuticals Ltd

cb torrentpharma.com

Torrent Pharma, with annual revenues of more than Rs 10,700 crores, is the flagship Company of the Torrent Group, with group revenues of Rs 41,000 crores. It is ranked 5th in the Indian Pharma Market and is among the Top 5 in the therapeutic segments of Cardiovascular (CV), Central Nervous System (CNS), Gastro-intestinal (GI), Vitamins Minerals Nutritionals (VMN) and Cosmo-Dermatology. The Company also has significant presence in diabetology, pain management, gynaecology, oncology and anti-infective segments. Torrent has 8 manufacturing facilities , of which 5 are USFDA approved. With R&D as the backbone for its growth in domestic & overseas market, it has invested significantly in R&D capabilities with state-of-the-art R&D infrastructure employing around 800 scientists. The acquisition of Elder Pharma's Indian branded business in 2013, Dermaceuticals business of Zyg Pharma in 2015, API plant of Glochem Industries in 2016, Women healthcare brands from Novartis and Unichem's Indian branded business along with its Sikkim Plant in 2017 strengthened Torrent Pharma's position in the Indian Pharma market. Torrent Pharma started international acquisitions in 2005 with entry into the German market. Today, the Company has presence in more than 50 countries and is ranked No. 1 among the Indian pharma Companies in Brazil and Germany. Torrent Pharma is committed towards “not just healthcare but lifecare.”

AbbVie

cb abbvie.com

AbbVie is a global biopharmaceutical company focused on creating medicines and solutions that put impact first — for patients, communities, and our world. We aim to address complex health issues and enhance people's lives through our core therapeutic areas: immunology, oncology, neuroscience, aesthetics and other areas of unmet need. Learn more about us at www.abbvie.com and review our community guidelines at https://www.abbvie.com/social-media-community-guidelines.html.

Ipca Laboratories Limited

ipca.com

A consumer-led global pharmaceutical company, creating healthy doses of life since 1949. When you operate in an industry like pharmaceuticals, your work goes way beyond creating ‘products for customers’. It is different from any other domain – there lies a higher sense of responsibiliti and a need for utmost integriti in everything you do. As you serve millions of lives, high qualiti standards become a pre-requisite, and safeti of your people and consumers always comes first. All this, while ensuring that each life you touch is treated with respect and digniti. For more than 60 years, Ipca has been a crucial healthcare partner in over 120 countries across the 6 continents. We are a fully-integrated pharmaceutical company that manufactures over 350 formulations and 80 APIs for various therapeutic segments. Today, we are one of the world’s largest manufacturers and suppliers of over a dozen APIs. These are produced from scratch at fully-automated manufacturing facilities, approved by the world’s most discerning drug regulatory authorities like UK-MHRA, EDQM-Europe, and WHO-Geneva, among others. - One of the largest suppliers of these APIs worldwide with manufacturing leadership in over 12 APIs globally - 15 APIs & 11 Formulations manufacturing facility across the globe Leader in DMARDs (Disease Modifying Anti-Rheumatic Drugs) treatment for Rheumatoid Arthritis - Leading brands in Pain, Rheumatology, Antimalarials and Hair care therapy - 4 formulations rank amongst the top 300 brands of IPM as per IQVIA

Lupin

lupin.com

Lupin Limited is a global pharmaceutical leader headquartered in Mumbai, India, with products distributed in over 100 markets. Lupin specializes in pharmaceutical products, including branded and generic formulations, complex generics, biotechnology products, and active pharmaceutical ingredients. Trusted by healthcare professionals and consumers globally, the company enjoys a strong position in India and the U.S. across multiple therapy areas, including respiratory, cardiovascular, anti-diabetic, anti-infective, gastrointestinal, central nervous system, and women’s health. Lupin has 15 state-of-the-art manufacturing sites and 7 research centers globally, along with a dedicated workforce of over 23,000 professionals. Lupin is committed to improving patient health outcomes through its subsidiaries – Lupin Diagnostics, Lupin Digital Health, and Lupin Manufacturing Solutions.

Alembic Pharmaceuticals Limited

alembic-india.com

Established in 1907, Alembic Pharmaceuticals Limited is a leading pharmaceutical company in India. The Company is vertically integrated with the ability to develop, manufacture and market pharmaceutical products, pharmaceutical substances and Intermediates. Alembic is the market leader in the Macrolides segment of anti-infective drugs in India. Alembic's manufacturing facilities are located in Vadodara and Baddi in Himachal Pradesh. The plant at Vadodara has the largest fermentation capacity in India. The Panelav facility houses the API and formulation manufacturing (both US FDA approved) plants. The plant at Baddi, Himachal Pradesh manufactures formulations for the domestic and non-regulated export market. The company has a state of the art Research Centre at Vadodara.

Eli Lilly and Company

lilly.com

We're a medicine company turning science into healing to make life better for people around the world. It all started nearly 150 years ago with a clear vision from founder Colonel Eli Lilly: "Take what you find here and make it better and better." Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing science to solve some of the world's most significant health challenges. General Information and Guidelines: When you engage with us on LinkedIn, you're agreeing to these Community Guidelines: https://e.lilly/guidelines. If you have questions about a Lilly medicine, contact The Lilly Answers Center at 1-800-Lilly-Rx (1-800-545-5979) Monday through Friday, excluding company holidays.

Viatris

viatris.com

Viatris Inc. (NASDAQ: VTRS) is a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally. With a mission to empower people worldwide to live healthier at every stage of life, we provide access at scale. In 2022 alone, we supplied high-quality medicines to approximately 1 billion patients around the world. With our exceptionally extensive and diverse portfolio of medicines, a one-of-a-kind global supply chain designed to reach more people when and where they need them, and the scientific expertise to address some of the world’s most enduring health challenges, access takes on deep meaning at Viatris. We have the ability to touch all of life’s moments, from birth to end of life, acute conditions to chronic diseases. We are headquartered in the U.S., with global centers in Pittsburgh, Shanghai and Hyderabad, India Social Media Guidelines: https://newsroom.viatris.com/social-media-community-guidelines Investors: https://investor.viatris.com Corporate Social Responsibility: https://www.viatris.com/sustainability Connect with Viatris Instagram: https://www.instagram.com/viatrisinc X: https://www.x.com/viatrisinc Viatris and our recruiting firms will not ask for sensitive personal information, such as your social security number, date of birth or bank account details via text, email or social media. Additionally, Viatris representatives do not request payment or personal bank information nor send payment to purchase hardware on your own. Viatris.com is the primary source of all company job postings and authorized third-party career websites.

Sandoz

sandoz.com

Sandoz is the global leader in generic and biosimilar medicines. Our Purpose is to pioneer access to medicines for patients globally. We are on a mission to drive innovation in the healthcare industry by freeing up resources sustainably and responsibly while continuing to address global health challenges such as antimicrobial resistance. We are present in more than 100 countries and our medicines serve some 500 million people every year. We have two main global businesses: Generics - divided between standard generics and complex generics - and Biosimilars. Read our community engagement guidelines: http://bit.ly/4ofoggc

Glenmark Pharmaceuticals

glenmarkpharma.com

Glenmark Pharmaceuticals Limited is a research-led, global organization committed to enriching lives. Innovation is deeply embedded in Glenmark’s culture; it is how we differentiate ourselves in our key markets and create greater value for our stakeholders. In our journey of innovation over the past four and a half decades, we have evolved from a generics company to a global organization offering specialty and branded products. Glenmark’s core values of Achievement, Respect, and Knowledge impart a sense of organizational unity that drives our growth. We have established a robust global branded generics, specialty, and OTC business; with a significant presence in the therapy areas of dermatology, respiratory, and oncology. Our ten state-of-the-art manufacturing facilities spread across four continents with operations in over 80 countries help us impact millions of patients across the globe. We recently consolidated our innovation efforts in small molecules and biologics research with the formation of ‘Ichnos Glenmark Innovation’ (IGI). This alliance is aimed at leveraging the capabilities of Glenmark and its subsidiary, Ichnos Sciences, to accelerate innovation in cancer treatment. To know more about IGI, check out: https://iginnovate.com/ Sustainability is an integral aspect of all our operations and we are focused on achieving our Environment, Social and Governance (ESG) goals. Our responsibility also extends to our communities, and over the years, our CSR efforts have touched the lives of over 3 million people.

Loading…

NEWS

Jubilant Pharmova Limited CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

September 17, 2025 07:00 AM

TechD Cybersecurity IPO allotment: How to check status online on NSE, Purva Sharegistry after 700x subscription

TechD Cybersecurity IPO allotment: The Vijay Kedia-backed firm, which had set a price band of ₹183 to ₹193 per share, sought to raise ₹38.99...

Read Article

January 31, 2025 08:00 AM

Bajaj Auto to take 'legal action' after it gets over Rs 10 cr GST penalty

Bajaj Auto Ltd on Friday said it has been imposed penalty and interest of over Rs 10 crore by the tax authority in a matter related to differential GST.

Read Article

August 02, 2024 07:00 AM

Meesho Onboards Four New Independent Directors

Meesho, India's only true e-commerce marketplace, today announced the appointment of four Independent Directors to its Board: Kalpana...

Read Article

January 07, 2022 11:09 PM

Jubilant Pharmova Share Price Today - Jubilant Pharmova Stock Price Live NSE/BSE

PRIYAVRAT BHARTIA, Promoter, 1,398,010, 0.9%. SPB TRUSTEE COMPANY PVT LTD, Promoter, 31,986,161, 20.1%. HSB TRUSTEE COMPANY PVT LTD, Promoter, 30,257,475...

Read Article

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-55867

SUMMARY

Graylog is a free and open log management platform. From 6.2.0 until 6.3.12, 7.0.7, and 7.1.2, the DELETE /users/{userId}/tokens/{idOrToken} endpoint implemented by UsersResource.revokeToken() in graylog2-server/src/main/java/org/graylog2/rest/resources/users/UsersResource.java checks USERS_TOKENREMOVE permission against the attacker-controlled userId path parameter before resolving the token selected by idOrToken. An authenticated user can provide an authorized userId while accessTokenService.loadById() or accessTokenService.load() resolves a token belonging to another user, including a service account or administrator, after which accessTokenService.destroy() deletes that token without checking AccessToken.getUserName(). The issue does not expose token contents, but unauthorized deletion causes integrity impact and can disrupt access-token-based integrations. This issue is fixed in versions 6.3.12, 7.0.7, and 7.1.2.

Published

Date2026-08-28

Updated

Date2026-08-28

RISK INFORMATION (Score: )

cvss4

Base Score: 5.3

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:N/VI:L/VA:L/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

Exploitability

REFERENCES

CVE-2026-55860

SUMMARY

MariaDB Connector/R2DBC is a non-blocking MariaDB and MySQL client implemented in Java. Prior to 1.4.1, org.mariadb:r2dbc-mariadb does not gate clear-text password authentication plugins on transport encryption because the AuthenticationPlugin interface has no capability for a plugin to require a secure connection. A hostile or man-in-the-middle MariaDB server can send an AuthSwitchRequest naming mysql_clear_password or dialog (PAM) over a plain-TCP unencrypted connection, and AuthenticationFlow permits ClearPasswordPluginFlow or PamPluginFlow to return the user's password as cleartext bytes on the wire. The disclosed credentials can subsequently be used to authenticate directly to the database server. This issue is fixed in version 1.4.1.

Published

Date2026-08-28

Updated

Date2026-08-28

RISK INFORMATION (Score: 5.9)

cvss3

Base Score: 5.9

Complexity: HIGH

CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:U/C:H/I:N/A:N

Impact Score

3.6

Exploitability

2.2

REFERENCES

CVE-2026-55859

SUMMARY

MariaDB Connector/R2DBC is a non-blocking MariaDB and MySQL client implemented in Java. Prior to 1.4.1, org.mariadb:r2dbc-mariadb encodes and decodes all character data under the assumption that the connection character set is UTF-8. A server can announce a mid-session change to character_set_client through the OK-packet session-state-tracking mechanism, including through SET NAMES executed by a stored routine or trigger, server configuration, or a hostile or man-in-the-middle server. If the new character set is not UTF-8, the driver continues to exchange UTF-8 while the server interprets the same bytes under a different encoding, causing silent data corruption and a client/server charset-confusion mismatch that can defeat byte-wise quoting or escaping. The fix accepts only utf8, utf8mb3, or utf8mb4 after initialization; any other value raises R2dbcNonTransientResourceException with SQLState 08000 and closes the connection. This issue is fixed in version 1.4.1.

Published

Date2026-08-28

Updated

Date2026-08-28

RISK INFORMATION (Score: 5.9)

cvss3

Base Score: 5.9

Complexity: HIGH

CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:U/C:N/I:H/A:N

Impact Score

3.6

Exploitability

2.2

REFERENCES

CVE-2026-55858

SUMMARY

MariaDB Connector/J is used to connect applications developed in Java to MariaDB and MySQL databases. Prior to 2.7.14, 3.3.5, 3.4.3, and 3.5.9, the connector encodes and decodes protocol text and performs client-side escaping under the assumption that the connection character set is UTF-8. The server can report a mid-session change to character_set_client through OK-packet session-state tracking, including a change caused by SET NAMES, a stored routine or trigger, server configuration, or a hostile server. If character_set_client changes to a non-UTF-8 value, the driver continues to read and write UTF-8 while the server interprets the same bytes under another encoding, causing silent data corruption and a client/server charset-confusion mismatch that can defeat byte-wise quoting or escaping. The fix accepts only utf8, utf8mb3, or utf8mb4 after initialization; any other value causes SQLException with SQLState 08000 and closes the connection. This issue is fixed in versions 2.7.14, 3.3.5, 3.4.3, and 3.5.9.

Published

Date2026-08-28

Updated

Date2026-08-28

RISK INFORMATION (Score: 5.9)

cvss3

Base Score: 5.9

Complexity: HIGH

CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:U/C:N/I:H/A:N

Impact Score

3.6

Exploitability

2.2

REFERENCES

CVE-2026-55857

SUMMARY

MariaDB Connector/J is used to connect applications developed in Java to MariaDB and MySQL databases. Prior to 2.7.14, 3.3.5, 3.4.3, and 3.5.9, PAM dialog authentication can be coerced into transmitting the account password over an insecure connection. The mysql_clear_password plugin is gated behind a secure transport, but the sibling PAM handler SendPamAuthPacketFactory, named dialog by the server, does not declare that requirement and inherits the default secure-required value false; older branches implement the same affected behavior in SendPamAuthPacket. A hostile or man-in-the-middle server can send an Authentication Switch Request for dialog over plain TCP, causing the driver to return the user's password in cleartext when sslMode=DISABLE and restrictedAuth=null, which is the default configuration. Properly verified TLS and local Unix sockets are not exposed to this transport vector. This issue is fixed in versions 2.7.14, 3.3.5, 3.4.3, and 3.5.9.

Published

Date2026-08-28

Updated

Date2026-08-28

RISK INFORMATION (Score: 5.9)

cvss3

Base Score: 5.9

Complexity: HIGH

CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:U/C:H/I:N/A:N

Impact Score

3.6

Exploitability

2.2

REFERENCES

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…